Dual targeting by Artemisia rupestris L. disrupting TLR4/NF-κB signaling and macrophage driven immune evasion in hepatocellular carcinoma
- 9 December 2025
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 358, 121028
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82570069)
- National Natural Science Foundation of China (82170481)
- Suzhou University (2025KYCX07)
This publication has 27 references indexed in Scilit:
- Bioactive compounds from dichloromethane extract of Artemisia rupestris L. alleviates CCl4/ConA-induced acute liver injury by inhibiting PI3K-AKT pathwayJournal of Ethnopharmacology, 2024
- Exploring the molecular mechanism of Artemisia rupestris L. for the treatment of hepatocellular carcinoma via PI3K/AKT pathwayJournal of Ethnopharmacology, 2023
- Citri Reticulatae Pericarpium extract and flavonoids reduce inflammation in RAW 264.7 macrophages by inactivation of MAPK and NF‐κB pathwaysFood Frontiers, 2022
- Inflammation: the incubator of the tumor microenvironmentTrends in Cancer, 2022
- TNF in the liver: targeting a central player in inflammationSeminars in Immunopathology, 2022
- Tumor microenvironment as a therapeutic target in cancerPharmacology & Therapeutics, 2020
- Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapyCancer Letters, 2020
- Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandilBiomedicine & Pharmacotherapy, 2018
- Macrophage plasticity, polarization, and function in health and diseaseJournal of Cellular Physiology, 2018
- Metabolic and Epigenetic Coordination of T Cell and Macrophage ImmunityImmunity, 2017